Clinical Trial Update: Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the use of ketamine as an anesthetic during electroconvulsive therapy for major depressive episodes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Northside Clinic, Australia | Conditions: Major Depressive Episode | Phase 4 | Status: COMPLETED